CANNAPHARMARX, INC. Proceeds from Sale of Intangible Assets
CANNAPHARMARX, INC. (CPMD) reported Proceeds from Sale of Intangible Assets of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2021-11-15
- CANNAPHARMARX, INC. proceeds from sale of intangible assets for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. proceeds from sale of intangible assets for the quarter ending 2020-12-31 was -$95.68K.
- CANNAPHARMARX, INC. proceeds from sale of intangible assets for the quarter ending 2020-09-30 was $33.25K.
- CANNAPHARMARX, INC. proceeds from sale of intangible assets for the quarter ending 2019-12-31 was $0.00.
- CANNAPHARMARX, INC. proceeds from sale of intangible assets for fiscal 2020 was $0.00.
- CANNAPHARMARX, INC. proceeds from sale of intangible assets for fiscal 2019 was $0.00.
| Period end | Proceeds from Sale of Intangible Assets 3 month | Proceeds from Sale of Intangible Assets 6 month | Proceeds from Sale of Intangible Assets 9 month | Proceeds from Sale of Intangible Assets 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | -$95.68K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | -$62.44K derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-K · filed 2021-04-14 | |
| 2020-09-30 | $33.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $95.68K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $62.44K 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | $0.00 derived: sum of 2 quarters · filed 2021-04-14 | $0.00 10-K · filed 2021-04-14 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-19 |